We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome.
- Authors
Kaufmann, Christoph C.; Muthspiel, Marie; Lunzer, Laura; Pogran, Edita; Zweiker, David; Burger, Achim Leo; Wojta, Johann; Huber, Kurt
- Abstract
Acute coronary syndrome (ACS) remains a major challenge in clinical practice, requiring rapid and effective antithrombotic treatment to mitigate adverse ischemic events while minimizing the risk of bleeding. In recent years, results from several clinical trials addressing this issue through various approaches have substantially improved the treatment landscape for patients presenting with ACS. The emergence of new, potent P2Y12 inhibitors has significantly enhanced thrombotic risk reduction and different strategies for de-escalating and shortening dual antiplatelet therapy (DAPT) have demonstrated promising outcomes in reducing bleeding rates. Furthermore, data from ongoing trials focusing on novel therapeutic agents and investigating alternative treatment strategies to optimize outcomes for ACS patients are expected in the next few years. In this review, we summarize the current knowledge and emphasize the critical role of individualized treatment approaches tailored to patient-specific risk factors and individual clinical scenarios.
- Subjects
ACUTE coronary syndrome; PLATELET aggregation inhibitors; ANTICOAGULANTS
- Publication
Journal of Clinical Medicine, 2024, Vol 13, Issue 8, p2313
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm13082313